NCT06514118View on ClinicalTrials.gov

Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

March 16, 2026

Study Completion Date

March 16, 2027

Conditions
Small-cell Lung CancerResidual TumorRadiation
Interventions
RADIATION

residual tumor irradiation

lung residual tumor will be given external beam irradiation for 50GY in 25 fractions in total

Trial Locations (3)

266042

RECRUITING

Qingdao Central Hospital, Qingdao

RECRUITING

Qingdao Central Hospital, Qingdao

RECRUITING

Qingdao Central Hospital, Qingdao

All Listed Sponsors
lead

Qingdao Central Hospital

OTHER